Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Efficacy of remission-induction regimens for ANCA-associated vasculitis.
Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo
Synthetic Biologics Announces Issuance of U.S. Patent Adding Another Layer of Protection for the Use of Oral Estriol Candidate, Trimesta™, for Multiple Sclerosis
Emotional Change-Associated T Cell Mobilization at the Early Stage of a Mouse Model of Multiple Sclerosis.
The majority of CD1d-sulfatide-specific T cells in human blood use a semiinvariant Vδ1 TCR.
Mechanical environment modulates biological properties of oligodendrocyte progenitor cells.
Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS.
Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes.
Patient reported outcome measures in neurogenic bladder.
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants.
Multiple sclerosis: risk factors, prodromes, and potential causal pathways.
Rituximab in relapsing and progressive forms of multiple sclerosis: a systematic review.
What Explains Gray Matter Atrophy in Long-standing Multiple Sclerosis?
Natalizumab treatment during pregnancy - effects on the neonatal immune system.
Onset of multiple sclerosis before adulthood leads to failure of age-expected brain growth.
The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.
New multiple sclerosis phenotypic classification.
Functional effects of the antigen glatiramer acetate are complex and tightly associated with its composition.
Fatal toxic epidermal necrolysis in a patient on teriflunomide treatment for relapsing multiple sclerosis.
Involvement of AMPK, IKβα-NFκB and eNOS in the sildenafil anti-inflammatory mechanism in a demyelination model.
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system.
Novel therapies for memory cells in autoimmune diseases.
Nasal administration of drugs as a new non-invasive strategy for efficient treatment of multiple sclerosis.
Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis.
Dose titration of BAF312 attenuates the initial heart rate reducing effect in healthy subjects.

Pages